Corporate News

Novartis Q2 Results Climb, Top Estimates; Maintains FY21 Outlook - Quick Facts

Swiss drug major Novartis (NVS) reported Wednesday that its second-quarter net income climbed 55 percent to $2.90 billion from last year's $1.87 billion, driven by momentum of key growth brands.

Earnings per share grew 57 percent to $1.29 from prior year's $0.82.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More Corporate News